A phase 2 trial of Tisotumab vedotin monotherapy in a range of other solid tumor types.
Phase of Trial: Phase II
Latest Information Update: 08 Feb 2018
At a glance
- Drugs Tisotumab-vedotin (Primary)
- Indications Solid tumours
- Focus Therapeutic Use
- 08 Feb 2018 New trial record
- 06 Feb 2018 According to a Astellas Pharma media release, company is planning to begin this trial in 2018.